Skip to main content
Top
Published in: BMC Pediatrics 1/2022

Open Access 01-12-2022 | Obesity | Research

Growth and Nutritional Status of Phenylketonuric Children and Adolescents

Authors: Mina Ahmadzadeh, Golbon Sohrab, Mohammadreza Alaei, Hassan Eini-Zinab, Behzad mohammadpour-Ahranjani, Samira Rastgoo, Zahra Namkhah

Published in: BMC Pediatrics | Issue 1/2022

Login to get access

Abstract

Background

The goal of this study was to assess the anthropometric and biochemical parameters of children and adolescents with phenylketonuria (PKU).

Methods

The participants in this cross-sectional study ranged in age from four to 18 years old. Biochemical markers such as vitamin B12, folic acid, iron, ferritin, calcium, 25-hydroxy vitamin D3, zinc, plasma phenylalanine (Phe) and tyrosine (Tyr) levels in blood were evaluated, as well as demographics and anthropometric measurements. A three-day dietary recall questionnaire was completed by all individuals.

Results

80% (64) of the 80 patients (42 females, 52.5%) had typical PKU. Consanguineous marriages were found in 57.5% (46) of the patients’ parents. According to the height for age index, 17.5% of the study group (n = 14) were short or very short. According to age-related weight and body mass index (BMI), 37.5% (n = 30) and 43.8% (n = 35) of people are obese or overweight, respectively. Biochemical tests revealed increased vitamin B12 levels and 25-hydroxy vitamin D3 deficiency in 35% (n = 28) of the patients, insufficient folic acid in 12.5% (n = 10), and elevated phenylalanine levels in 70.3% (n = 45) of children under 12 years old, and adolescents 62.5% (n = 10). A high Phe intake (OR = 4.44, CI %95 = 1.27–15.57) is a risk factor for obesity and overweight.

Conclusion

Patients with PKU had a high rate of overweight and obesity. PKU patients who are overweight or obese do not differ from normal-weight patients in terms of dietary intake or laboratory findings (except for serum iron levels). One-third of patients with phenylketonuria were vitamin D deficient and had a BMI/A index of overweight/obese. It is recommended to use special medical food to help solve energy and nutrient deficiencies.
Literature
1.
go back to reference Ekin S, Dogan M, Gok F, Karakus Y. Assessment of antioxidant enzymes, total sialic acid, lipid bound sialic acid, vitamins and selected amino acids in children with phenylketonuria. Pediatr Res. 2018;84(6):821–8.CrossRefPubMed Ekin S, Dogan M, Gok F, Karakus Y. Assessment of antioxidant enzymes, total sialic acid, lipid bound sialic acid, vitamins and selected amino acids in children with phenylketonuria. Pediatr Res. 2018;84(6):821–8.CrossRefPubMed
2.
go back to reference Chu K, editor Phenylketonuria: Research and development of nutrition. AIP Conference Proceedings; 2020: AIP Publishing LLC. Chu K, editor Phenylketonuria: Research and development of nutrition. AIP Conference Proceedings; 2020: AIP Publishing LLC.
3.
go back to reference Parra GAM, Singh RH, Cetinyurek-Yavuz A, Kuhn M, MacDonald A. Status of nutrients important in brain function in phenylketonuria: a systematic review and meta-analysis. Orphanet J Rare Dis. 2018;13(1):101.CrossRef Parra GAM, Singh RH, Cetinyurek-Yavuz A, Kuhn M, MacDonald A. Status of nutrients important in brain function in phenylketonuria: a systematic review and meta-analysis. Orphanet J Rare Dis. 2018;13(1):101.CrossRef
4.
go back to reference van Spronsen FJ, van Wegberg AM, Ahring K, Bélanger-Quintana A, Blau N, Bosch AM, et al. Key European guidelines for the diagnosis and management of patients with phenylketonuria. The lancet Diabetes & endocrinology. 2017;5(9):743–56.CrossRef van Spronsen FJ, van Wegberg AM, Ahring K, Bélanger-Quintana A, Blau N, Bosch AM, et al. Key European guidelines for the diagnosis and management of patients with phenylketonuria. The lancet Diabetes & endocrinology. 2017;5(9):743–56.CrossRef
5.
go back to reference Guerra IM, Ferreira HB, Neves B, Melo T, Diogo LM, Domingues MR, et al. Lipids and phenylketonuria: Current evidences pointed the need for lipidomics studies. Archives of Biochemistry and Biophysics. 2020:108431. Guerra IM, Ferreira HB, Neves B, Melo T, Diogo LM, Domingues MR, et al. Lipids and phenylketonuria: Current evidences pointed the need for lipidomics studies. Archives of Biochemistry and Biophysics. 2020:108431.
6.
go back to reference Ney DM, Blank RD, Hansen KE. Advances in the nutritional and pharmacological management of phenylketonuria. Curr Opin Clin Nutr Metab Care. 2014;17(1):61.PubMedPubMedCentral Ney DM, Blank RD, Hansen KE. Advances in the nutritional and pharmacological management of phenylketonuria. Curr Opin Clin Nutr Metab Care. 2014;17(1):61.PubMedPubMedCentral
7.
go back to reference Heidari A, Arab M, Etemad K, Damari B, Lotfi M. National Phenylketonuria screening program in iran; why and how. J School Public Health Inst Public Health Res. 2018;16(2):148–63. Heidari A, Arab M, Etemad K, Damari B, Lotfi M. National Phenylketonuria screening program in iran; why and how. J School Public Health Inst Public Health Res. 2018;16(2):148–63.
8.
go back to reference Demirkol M, Giżewska M, Giovannini M, Walter J. Follow up of phenylketonuria patients. Mol Genet Metab. 2011;104:31-S9.CrossRef Demirkol M, Giżewska M, Giovannini M, Walter J. Follow up of phenylketonuria patients. Mol Genet Metab. 2011;104:31-S9.CrossRef
9.
go back to reference Yuskiv N, Potter BK, Stockler S, Ueda K, Giezen A, Cheng B, et al. Nutritional management of phenylalanine hydroxylase (PAH) deficiency in pediatric patients in Canada: a survey of dietitians’ current practices. Orphanet J Rare Dis. 2019;14(1):7.CrossRefPubMedPubMedCentral Yuskiv N, Potter BK, Stockler S, Ueda K, Giezen A, Cheng B, et al. Nutritional management of phenylalanine hydroxylase (PAH) deficiency in pediatric patients in Canada: a survey of dietitians’ current practices. Orphanet J Rare Dis. 2019;14(1):7.CrossRefPubMedPubMedCentral
10.
go back to reference Green B, Browne R, Firman S, Hill M, Rahman Y, Kaalund Hansen K, et al. Nutritional and metabolic characteristics of UK adult phenylketonuria patients with varying dietary adherence. Nutrients. 2019;11(10):2459.CrossRefPubMedCentral Green B, Browne R, Firman S, Hill M, Rahman Y, Kaalund Hansen K, et al. Nutritional and metabolic characteristics of UK adult phenylketonuria patients with varying dietary adherence. Nutrients. 2019;11(10):2459.CrossRefPubMedCentral
11.
go back to reference Das A, Goedecke K, Meyer U, Kanzelmeyer N, Koch S, Illsinger S, et al. Dietary habits and metabolic control in adolescents and young adults with phenylketonuria: self-imposed protein restriction may be harmful. JIMD Reports-Case and Research Reports, Volume 13: Springer; 2013. p. 149 – 58. Das A, Goedecke K, Meyer U, Kanzelmeyer N, Koch S, Illsinger S, et al. Dietary habits and metabolic control in adolescents and young adults with phenylketonuria: self-imposed protein restriction may be harmful. JIMD Reports-Case and Research Reports, Volume 13: Springer; 2013. p. 149 – 58.
12.
go back to reference Pinto A, Almeida M, Ramos P, Rocha S, Guimas A, Ribeiro R, et al. Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source. Eur J Clin Nutr. 2017;71(10):1230–4.CrossRefPubMed Pinto A, Almeida M, Ramos P, Rocha S, Guimas A, Ribeiro R, et al. Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source. Eur J Clin Nutr. 2017;71(10):1230–4.CrossRefPubMed
13.
go back to reference Weng H-L, Yang F-J, Chen P-R, Hwu W-L, Lee N-C, Chien Y-H. Dietary intake and nutritional status of patients with phenylketonuria in Taiwan. Sci Rep. 2020;10(1):1–6.CrossRef Weng H-L, Yang F-J, Chen P-R, Hwu W-L, Lee N-C, Chien Y-H. Dietary intake and nutritional status of patients with phenylketonuria in Taiwan. Sci Rep. 2020;10(1):1–6.CrossRef
14.
go back to reference Camatta GC, de Cássia Kanufre V, Alves MRA, Soares RDL, de Carvalho Norton R, de Aguiar MJB, et al. Body fat percentage in adolescents with phenylketonuria and associated factors. Mol Genet Metabolism Rep. 2020;23:100595.CrossRef Camatta GC, de Cássia Kanufre V, Alves MRA, Soares RDL, de Carvalho Norton R, de Aguiar MJB, et al. Body fat percentage in adolescents with phenylketonuria and associated factors. Mol Genet Metabolism Rep. 2020;23:100595.CrossRef
15.
go back to reference Hansen J, Hollander S, Drilias N, Van Calcar S, Rohr F, Bernstein L. Simplified Diet for nutrition management of phenylketonuria: A survey of US metabolic dietitians. JIMD Rep. 2020;53(1):83–9.CrossRefPubMedPubMedCentral Hansen J, Hollander S, Drilias N, Van Calcar S, Rohr F, Bernstein L. Simplified Diet for nutrition management of phenylketonuria: A survey of US metabolic dietitians. JIMD Rep. 2020;53(1):83–9.CrossRefPubMedPubMedCentral
16.
go back to reference Clocksin HE, Hawks ZW, White DA, Christ SE. Inter-and intra-tract analysis of white matter abnormalities in individuals with early-treated phenylketonuria (PKU). Molecular Genetics and Metabolism. 2020. Clocksin HE, Hawks ZW, White DA, Christ SE. Inter-and intra-tract analysis of white matter abnormalities in individuals with early-treated phenylketonuria (PKU). Molecular Genetics and Metabolism. 2020.
17.
go back to reference Ceberio L, Hermida Á, Venegas E, Arrieta F, Morales M, Forga M, et al. Phenylketonuria in the adult patient. Expert Opin Orphan Drugs. 2019;7(6):265–76.CrossRef Ceberio L, Hermida Á, Venegas E, Arrieta F, Morales M, Forga M, et al. Phenylketonuria in the adult patient. Expert Opin Orphan Drugs. 2019;7(6):265–76.CrossRef
18.
go back to reference Matic J, Zeltner NA, Häberle J. Normal Growth in PKU Patients Under Low-Protein Diet in a Single-Center Cross-Sectional Study. JIMD Reports, Volume 43: Springer; 2018. p. 1–6. Matic J, Zeltner NA, Häberle J. Normal Growth in PKU Patients Under Low-Protein Diet in a Single-Center Cross-Sectional Study. JIMD Reports, Volume 43: Springer; 2018. p. 1–6.
19.
go back to reference El-Metwally A, Yousef Al-Ahaidib L, Ayman Sunqurah A, Al-Surimi K, Househ M, Alshehri A, et al. The Prevalence of Phenylketonuria in Arab Countries, Turkey, and Iran: A Systematic Review. Biomed Res Int. 2018;2018:7697210.CrossRefPubMedPubMedCentral El-Metwally A, Yousef Al-Ahaidib L, Ayman Sunqurah A, Al-Surimi K, Househ M, Alshehri A, et al. The Prevalence of Phenylketonuria in Arab Countries, Turkey, and Iran: A Systematic Review. Biomed Res Int. 2018;2018:7697210.CrossRefPubMedPubMedCentral
20.
go back to reference Saadatinasab Z, Sharifzadeh G. Incidence of Phenylketonuria in Southern Khorasan (2012–2014). J Birjand Univ Med Sci. 2015;22(3):286–92. Saadatinasab Z, Sharifzadeh G. Incidence of Phenylketonuria in Southern Khorasan (2012–2014). J Birjand Univ Med Sci. 2015;22(3):286–92.
21.
go back to reference Morovatdar N, Badiee Aval S, Hosseini Yazdi SMR, Norouzi F, Mina T. Epidemiology and clinical study of phenylketonuria (PKU) patients in Khorasan Province; Norteast Iran. Iran J Neonatology IJN. 2015;6(1):18–22. Morovatdar N, Badiee Aval S, Hosseini Yazdi SMR, Norouzi F, Mina T. Epidemiology and clinical study of phenylketonuria (PKU) patients in Khorasan Province; Norteast Iran. Iran J Neonatology IJN. 2015;6(1):18–22.
22.
go back to reference MacDonald A, Van Wegberg A, Ahring K, Beblo S, Bélanger-Quintana A, Burlina A, et al. PKU dietary handbook to accompany PKU guidelines. Orphanet J Rare Dis. 2020;15(1):1–21. MacDonald A, Van Wegberg A, Ahring K, Beblo S, Bélanger-Quintana A, Burlina A, et al. PKU dietary handbook to accompany PKU guidelines. Orphanet J Rare Dis. 2020;15(1):1–21.
23.
go back to reference Zendehdel M, Tamimi M, Zadkarami M, Karandish M, Aminzadeh M. Anthropometric Assessment and some of Contributing Factors in Control of Phenylketonuria Patients in Khuzestan Province. Jundishapur Scientific Medical Journal. 2014;13(1). Zendehdel M, Tamimi M, Zadkarami M, Karandish M, Aminzadeh M. Anthropometric Assessment and some of Contributing Factors in Control of Phenylketonuria Patients in Khuzestan Province. Jundishapur Scientific Medical Journal. 2014;13(1).
24.
go back to reference Geiger KE, Koeller DM, Harding CO, Huntington KL, Gillingham MB. Normal vitamin D levels and bone mineral density among children with inborn errors of metabolism consuming medical food–based diets. Nutr Res. 2016;36(1):101–8.CrossRefPubMed Geiger KE, Koeller DM, Harding CO, Huntington KL, Gillingham MB. Normal vitamin D levels and bone mineral density among children with inborn errors of metabolism consuming medical food–based diets. Nutr Res. 2016;36(1):101–8.CrossRefPubMed
25.
go back to reference Montoya Parra GA, Singh RH, Cetinyurek-Yavuz A, Kuhn M, MacDonald A. Status of nutrients important in brain function in phenylketonuria: a systematic review and meta-analysis. Orphanet J Rare Dis. 2018;13(1):101.CrossRefPubMedPubMedCentral Montoya Parra GA, Singh RH, Cetinyurek-Yavuz A, Kuhn M, MacDonald A. Status of nutrients important in brain function in phenylketonuria: a systematic review and meta-analysis. Orphanet J Rare Dis. 2018;13(1):101.CrossRefPubMedPubMedCentral
26.
go back to reference Acosta P, Yannicelli S, Abbott L. Ross Products D. Nutrition support protocols: the Ross metabolic formula system Columbus. Ohio: Ross Products Division, Abbot Laboratories; 2001. Acosta P, Yannicelli S, Abbott L. Ross Products D. Nutrition support protocols: the Ross metabolic formula system Columbus. Ohio: Ross Products Division, Abbot Laboratories; 2001.
27.
go back to reference Okano Y, Hattori T, Fujimoto H, Noi K, Okamoto M, Watanabe T, et al. Nutritional status of patients with phenylketonuria in Japan. Mol Genet Metabolism Rep. 2016;8:103–10.CrossRef Okano Y, Hattori T, Fujimoto H, Noi K, Okamoto M, Watanabe T, et al. Nutritional status of patients with phenylketonuria in Japan. Mol Genet Metabolism Rep. 2016;8:103–10.CrossRef
28.
go back to reference Eshraghi P, Abbaskhanian A, Bijani A, Hosseinzadeh S. Evaluation of Nutritional Status and Growth in Phenylketonuria Patients in Mazandaran Province Iran. J Babol Univ Med Sci. 2011;13(5):58–62. Eshraghi P, Abbaskhanian A, Bijani A, Hosseinzadeh S. Evaluation of Nutritional Status and Growth in Phenylketonuria Patients in Mazandaran Province Iran. J Babol Univ Med Sci. 2011;13(5):58–62.
29.
go back to reference Crujeiras V, Aldámiz-Echevarría L, Dalmau J, Vitoria I, Andrade F, Roca I, et al. Vitamin and mineral status in patients with hyperphenylalaninemia. Mol Genet Metab. 2015;115(4):145–50.CrossRefPubMed Crujeiras V, Aldámiz-Echevarría L, Dalmau J, Vitoria I, Andrade F, Roca I, et al. Vitamin and mineral status in patients with hyperphenylalaninemia. Mol Genet Metab. 2015;115(4):145–50.CrossRefPubMed
30.
go back to reference Demirdas S, van Spronsen FJ, Hollak CE, van der Lee JH, Bisschop PH, Vaz FM, et al. Micronutrients, essential fatty acids and bone health in phenylketonuria. Annals of Nutrition and Metabolism. 2017;70(2):111–21.CrossRefPubMed Demirdas S, van Spronsen FJ, Hollak CE, van der Lee JH, Bisschop PH, Vaz FM, et al. Micronutrients, essential fatty acids and bone health in phenylketonuria. Annals of Nutrition and Metabolism. 2017;70(2):111–21.CrossRefPubMed
31.
go back to reference Pimentel FB, Alves RC, Costa AS, Fernandes TJ, Torres D, Almeida MF, et al. Nutritional composition of low protein and phenylalanine-restricted dishes prepared for phenylketonuric patients. LWT-Food Sci Technol. 2014;57(1):283–9.CrossRef Pimentel FB, Alves RC, Costa AS, Fernandes TJ, Torres D, Almeida MF, et al. Nutritional composition of low protein and phenylalanine-restricted dishes prepared for phenylketonuric patients. LWT-Food Sci Technol. 2014;57(1):283–9.CrossRef
32.
go back to reference Vugteveen I, Hoeksma M, Monsen A-LB, Fokkema MR, Reijngoud D-J, van Rijn M, et al. Serum vitamin B12 concentrations within reference values do not exclude functional vitamin B12 deficiency in PKU patients of various ages. Mol Genet Metab. 2011;102(1):13–7.CrossRefPubMed Vugteveen I, Hoeksma M, Monsen A-LB, Fokkema MR, Reijngoud D-J, van Rijn M, et al. Serum vitamin B12 concentrations within reference values do not exclude functional vitamin B12 deficiency in PKU patients of various ages. Mol Genet Metab. 2011;102(1):13–7.CrossRefPubMed
33.
go back to reference Doulgeraki A, Skarpalezou A, Theodosiadou A, Monopolis I, Schulpis K. Body composition profile of young patients with phenylketonuria and mild hyperphenylalaninemia. International journal of endocrinology and metabolism. 2014;12(3). Doulgeraki A, Skarpalezou A, Theodosiadou A, Monopolis I, Schulpis K. Body composition profile of young patients with phenylketonuria and mild hyperphenylalaninemia. International journal of endocrinology and metabolism. 2014;12(3).
34.
go back to reference Verduci E, Banderali G, Moretti F, Lassandro C, Cefalo G, Radaelli G, et al. Diet in children with phenylketonuria and risk of cardiovascular disease: A narrative overview. Nutr Metabolism Cardiovasc Dis. 2016;26(3):171–7.CrossRef Verduci E, Banderali G, Moretti F, Lassandro C, Cefalo G, Radaelli G, et al. Diet in children with phenylketonuria and risk of cardiovascular disease: A narrative overview. Nutr Metabolism Cardiovasc Dis. 2016;26(3):171–7.CrossRef
35.
go back to reference Aldámiz-Echevarría L, Bueno MA, Couce ML, Lage S, Dalmau J, Vitoria I, et al. Anthropometric characteristics and nutrition in a cohort of PAH-deficient patients. Clin Nutr. 2014;33(4):702–17.CrossRefPubMed Aldámiz-Echevarría L, Bueno MA, Couce ML, Lage S, Dalmau J, Vitoria I, et al. Anthropometric characteristics and nutrition in a cohort of PAH-deficient patients. Clin Nutr. 2014;33(4):702–17.CrossRefPubMed
36.
go back to reference Robertson L, McStravick N, Ripley S, Weetch E, Donald S, Adam S, et al. Body mass index in adult patients with diet-treated phenylketonuria. J Hum Nutr Dietetics. 2013;26:1–6.CrossRef Robertson L, McStravick N, Ripley S, Weetch E, Donald S, Adam S, et al. Body mass index in adult patients with diet-treated phenylketonuria. J Hum Nutr Dietetics. 2013;26:1–6.CrossRef
37.
go back to reference VANESSA. SHAW M, RD F. Clinical paediatric dietetics: Wiley Online Library; 2020. VANESSA. SHAW M, RD F. Clinical paediatric dietetics: Wiley Online Library; 2020.
38.
go back to reference de Almeida BNdF, Laufer JA, Mezzomo TR, Shimada NC, Furtado IHF, Dias MRMG, et al. Nutritional and metabolic parameters of children and adolescents with phenylketonuria. Clinical Nutrition ESPEN. 2020. de Almeida BNdF, Laufer JA, Mezzomo TR, Shimada NC, Furtado IHF, Dias MRMG, et al. Nutritional and metabolic parameters of children and adolescents with phenylketonuria. Clinical Nutrition ESPEN. 2020.
39.
go back to reference Mazzola PN, Nalin T, Castro K, van Rijn M, Derks TG, Perry ID, et al. Analysis of body composition and nutritional status in Brazilian phenylketonuria patients. Mol Genet metabolism Rep. 2016;6:16–20.CrossRef Mazzola PN, Nalin T, Castro K, van Rijn M, Derks TG, Perry ID, et al. Analysis of body composition and nutritional status in Brazilian phenylketonuria patients. Mol Genet metabolism Rep. 2016;6:16–20.CrossRef
40.
41.
go back to reference Shakiba M, Alaei M, Saneifard H, Mosallanejad A. Assessment of anthropometric indices in patients with phenylketonuria. Iran J Child Neurol. 2020;14(2):27.PubMedPubMedCentral Shakiba M, Alaei M, Saneifard H, Mosallanejad A. Assessment of anthropometric indices in patients with phenylketonuria. Iran J Child Neurol. 2020;14(2):27.PubMedPubMedCentral
42.
go back to reference Barretto JR, Silva LR, Leite ME, Boa-Sorte N, Pimentel H, Purificação AC, et al. Poor zinc and selenium status in phenylketonuric children and adolescents in Brazil. Nutr Res. 2008;28(3):208–11.CrossRefPubMed Barretto JR, Silva LR, Leite ME, Boa-Sorte N, Pimentel H, Purificação AC, et al. Poor zinc and selenium status in phenylketonuric children and adolescents in Brazil. Nutr Res. 2008;28(3):208–11.CrossRefPubMed
43.
go back to reference Saunders AV, Craig WJ, Baines SK. Zinc and vegetarian diets. Med J Australia. 2013;199(4):17–21. Saunders AV, Craig WJ, Baines SK. Zinc and vegetarian diets. Med J Australia. 2013;199(4):17–21.
44.
go back to reference Evans S, Daly A, MacDonald J, Preece MA, Santra S, Vijay S, et al. The micronutrient status of patients with phenylketonuria on dietary treatment: an ongoing challenge. Annals of Nutrition and Metabolism. 2014;65(1):42–8.CrossRefPubMed Evans S, Daly A, MacDonald J, Preece MA, Santra S, Vijay S, et al. The micronutrient status of patients with phenylketonuria on dietary treatment: an ongoing challenge. Annals of Nutrition and Metabolism. 2014;65(1):42–8.CrossRefPubMed
45.
go back to reference Kose E, Arslan N. Vitamin/mineral and micronutrient status in patients with classical phenylketonuria. Clin Nutr. 2019;38(1):197–203.CrossRefPubMed Kose E, Arslan N. Vitamin/mineral and micronutrient status in patients with classical phenylketonuria. Clin Nutr. 2019;38(1):197–203.CrossRefPubMed
Metadata
Title
Growth and Nutritional Status of Phenylketonuric Children and Adolescents
Authors
Mina Ahmadzadeh
Golbon Sohrab
Mohammadreza Alaei
Hassan Eini-Zinab
Behzad mohammadpour-Ahranjani
Samira Rastgoo
Zahra Namkhah
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2022
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-022-03715-2

Other articles of this Issue 1/2022

BMC Pediatrics 1/2022 Go to the issue